T
TRVI
Trevi Therapeutics
13.13
+0.03+0.23%Opening13:33 04/08 EDT
OPEN/PREV CLOSE13.49/13.10
TODAY RANGE12.74-13.59
VOL564.71K
MARKET CAP1.69B
52 WEEK RANGE4.850-14.39
AVG VOL (3M)1.37M
% TURNOVER0.44%
TURNOVER--
P/E (TTM)-41.3804
% RANGE6.46%
EPS(TTM)-0.3173
P/E(FORWARD)-29.1778
P/B9.19
BVPS1.428
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.50B
SHARES OUTSTANDING128.40M
NEXT EARNINGS05/06-05/11
FREE FLOAT113.97M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·03/19 19:59
Trevi Therapeutics Price Target Cut to $24.00/Share From $25.00 by Jones Trading
Dow Jones·03/19 19:59
Trevi Therapeutics Is Maintained at Buy by Jones Trading
TipRanks·03/19 12:45
Trevi Therapeutics price target lowered to $24 from $25 at JonesResearch
TipRanks·03/19 00:08
Trevi Therapeutics Maps Phase III Path and Runway
Benzinga·03/18 16:52
These Analysts Revise Their Forecasts On Trevi Therapeutics Following Q4 Earnings
Dow Jones·03/18 15:48
Trevi Therapeutics Price Target Cut to $18.00/Share From $19.00 by Morgan Stanley
Dow Jones·03/18 15:48
Trevi Therapeutics Is Maintained at Overweight by Morgan Stanley
Dow Jones·03/18 12:32
Trevi Therapeutics Price Target Maintained With a $19.00/Share by D. Boral Capital
Dow Jones·03/18 12:32
Trevi Therapeutics Is Maintained at Buy by D. Boral Capital
TipRanks·03/18 12:19
Trevi Therapeutics price target lowered to $18 from $19 at Morgan Stanley
Benzinga·03/18 12:19
Nvidia To Rally Around 79%? Here Are 10 Top Analyst Forecasts For Wednesday
Same Industry
Name/Symbol
Change%
Price